Live Breaking News & Updates on Pharmaceuticals revenues

Stay informed with the latest breaking news from Pharmaceuticals revenues on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharmaceuticals revenues and stay connected to the pulse of your community

TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations

TFF Pharmaceuticals ( NASDAQ:TFFP ) Full Year 2023 Results Key Financial Results Net loss: US$21.2m (loss narrowed by...

Pharmaceuticals-revenues , Earnings-miss , Pharmaceuticals-industry , Arnings-per-share , Harmaceuticals , Ff ,

Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from...

Oramed-pharmaceuticals-revenues , Oramed-pharmaceuticals , Pharmaceuticals-revenues , Earnings-beat ,

Kiniksa Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) Full Year 2023 Results Key Financial Results Revenue: US$270.3m (up 23% from FY...

Kiniksa-pharmaceuticals , Kiniksa-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-beat ,

Crinetics Pharmaceuticals Full Year 2023 Earnings: Misses Expectations

Crinetics Pharmaceuticals ( NASDAQ:CRNX ) Full Year 2023 Results Key Financial Results Net loss: US$214.5m (loss...

Crinetics-pharmaceuticals-revenues , Crinetics-pharmaceuticals , Pharmaceuticals-revenues , Earnings-miss ,

Supernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Supernus Pharmaceuticals ( NASDAQ:SUPN ) Full Year 2023 Results Key Financial Results Revenue: US$607.5m (down 8.9...

Supernus-pharmaceuticals , Supernus-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-beat ,

Ligand Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Ligand Pharmaceuticals ( NASDAQ:LGND ) Full Year 2023 Results Key Financial Results Revenue: US$131.3m (down 33% from...

Ligand-pharmaceuticals-revenues , Ligand-pharmaceuticals , Pharmaceuticals-revenues , Earnings-beat , Harmaceuticals-industry , Arnings-per-share , Y ,

Ionis Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Ionis Pharmaceuticals ( NASDAQ:IONS ) Full Year 2023 Results Key Financial Results Revenue: US$788.0m (up 34% from FY...

Ionis-pharmaceuticals , Ionis-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-beat , Arnings-per-share , Evenue-growth , Y ,

Arrowhead Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations

Arrowhead Pharmaceuticals ( NASDAQ:ARWR ) First Quarter 2024 Results Key Financial Results Revenue: US$3.55m (down 94...

Arrowhead-pharmaceuticals , Arrowhead-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-miss , Arnings-per-share , Evenue-growth , Nalyst-estimates ,

Agios Pharmaceuticals Second Quarter 2023 Earnings: Beats Expectations

Agios Pharmaceuticals ( NASDAQ:AGIO ) Second Quarter 2023 Results Key Financial Results Revenue: US$6.71m (up 20% from...

Agios-pharmaceuticals-revenues , Agios-pharmaceuticals , Pharmaceuticals-revenues , Earnings-beat , Arnings-per-share , Evenue-growth ,

Live Breaking News & Updates on Pharmaceuticals revenues

TFF Pharmaceuticals ( NASDAQ:TFFP ) Full Year 2023 Results Key Financial Results Net loss: US$21.2m (loss narrowed by...Pharmaceuticals-revenues , Earnings-miss , Pharmaceuticals-industry , Arnings-per-share , Harmaceuticals , Ff ,

Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from...Oramed-pharmaceuticals-revenues , Oramed-pharmaceuticals , Pharmaceuticals-revenues , Earnings-beat ,

Kiniksa Pharmaceuticals ( NASDAQ:KNSA ) Full Year 2023 Results Key Financial Results Revenue: US$270.3m (up 23% from FY...Kiniksa-pharmaceuticals , Kiniksa-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-beat ,

Crinetics Pharmaceuticals ( NASDAQ:CRNX ) Full Year 2023 Results Key Financial Results Net loss: US$214.5m (loss...Crinetics-pharmaceuticals-revenues , Crinetics-pharmaceuticals , Pharmaceuticals-revenues , Earnings-miss ,

Supernus Pharmaceuticals ( NASDAQ:SUPN ) Full Year 2023 Results Key Financial Results Revenue: US$607.5m (down 8.9...Supernus-pharmaceuticals , Supernus-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-beat ,

Ligand Pharmaceuticals ( NASDAQ:LGND ) Full Year 2023 Results Key Financial Results Revenue: US$131.3m (down 33% from...Ligand-pharmaceuticals-revenues , Ligand-pharmaceuticals , Pharmaceuticals-revenues , Earnings-beat , Harmaceuticals-industry , Arnings-per-share , Y ,

Ionis Pharmaceuticals ( NASDAQ:IONS ) Full Year 2023 Results Key Financial Results Revenue: US$788.0m (up 34% from FY...Ionis-pharmaceuticals , Ionis-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-beat , Arnings-per-share , Evenue-growth , Y ,

Arrowhead Pharmaceuticals ( NASDAQ:ARWR ) First Quarter 2024 Results Key Financial Results Revenue: US$3.55m (down 94...Arrowhead-pharmaceuticals , Arrowhead-pharmaceuticals-revenues , Pharmaceuticals-revenues , Earnings-miss , Arnings-per-share , Evenue-growth , Nalyst-estimates ,

Agios Pharmaceuticals ( NASDAQ:AGIO ) Second Quarter 2023 Results Key Financial Results Revenue: US$6.71m (up 20% from...Agios-pharmaceuticals-revenues , Agios-pharmaceuticals , Pharmaceuticals-revenues , Earnings-beat , Arnings-per-share , Evenue-growth ,